Vedic Lifesciences Pvt Ltd
Download
Report
Transcript Vedic Lifesciences Pvt Ltd
Vedic Lifesciences Pvt Ltd
Regulatory Requirements for Dietary
Supplements in USA
Mansi Ahuja
www.vediclifesciences.com
Health Regulators Worldwide
www.vediclifesciences.com
Status of AYUSH Products in USA
In USA
In INDIA
AYUSH Products
Dietary Supplements
Traditional Indian
Medicine
Herbal Supplements
Food Supplements
Patent & Proprietary or
Shastrokta Drugs
Can claim disease cure /
treatment
Cannot claim disease
cure, but only health
maintenance
Only OTC
Not reimbursed by
insurance
Can be prescribed or
OTC
www.vediclifesciences.com
Types of Health Regulations
“How To Enter” Regulations
(Pre-Market)
“What to Submit” Regulations
(Guidelines)
“What To Do” Regulations
(Marketing, Post-marketing)
www.vediclifesciences.com
“How To Enter” Regulations
Pre-Market
www.vediclifesciences.com
DSHEA,1994
The Dietary Supplement Health and Education Act was
signed into law in October, 1994.
Under DSHEA, a firm is responsible for
Safety of the dietary supplement
Claim Substantiation
www.vediclifesciences.com
Definition of Dietary Supplements
“The term ‘dietary supplement’ means a product (other than tobacco) intended
to supplement the diet that bears or contains one or more of the following
dietary ingredients:
(A) a vitamin;
(B) a mineral;
(C) an herb or other botanical;
(D) an amino acid;
(E) a dietary substance for use by man to supplement the diet by increasing the total
dietary intake; or
(F) a concentrate, metabolite, constituent, extract, or combination of any ingredient
described in clause (A), (B), (C), (D), or (E).”
Note: A dietary supplement is limited to products that are intended for
ingestion in tablet, capsule, powder, softgel, gelcap, and liquid form
www.vediclifesciences.com
Definition of Dietary Ingredient
New Dietary Ingredient (NDI): The term ‘new dietary
ingredient’ means a dietary ingredient that was not
marketed in the United States before October, 1994.
Old Dietary Ingredient (ODI): It means a dietary ingredient
that was marketed in the United States before October,
1994. (Grandfathered Ingredients)
In case of ODI, NO PRE MARKETING APPROVAL
REQUIRED from FDA.
However, pre marketing notification is required in case of NDI.
www.vediclifesciences.com
Dietary Supplement
ODI
NDI
Marketing
Success
OF
Marketin
g
Claims
www.vediclifesciences.com
Pre Market
Notification
Difference between Dietary Supplement,
Foods & Drugs
Dietary Supplement:
Supplements diet by
increasing the total
dietary intake
Drugs:
Diagnosis, Cure,
Mitigation, Treatment
or prevention of a
disease
Foods:
Principal Item of a
Person’s Diet
www.vediclifesciences.com
“What to Submit” Regulations
Guidelines
www.vediclifesciences.com
Notification Requirement for NDI
A pre – marketing notification is required in case of
Manufacturer who intends to market a new dietary
ingredient or dietary supplement that contains a new
dietary ingredient;
Distributor who intends to market a new dietary
ingredient or dietary supplement that contains a new
dietary ingredient.
www.vediclifesciences.com
Prerequisite for NDI
In order to market Dietary Supplement
containing NDI, the basic requirement is
pre marketing notification that must be
submitted 75 days prior to entry in the
market.
On September 23, 1997, FDA published in
the Federal Register a final rule that established
safety regulations.
www.vediclifesciences.com
Submission Information
Submit an original and two (2) copies of the
notification with Safety documents.
Notification should also contain the following data: Your name and complete address.
The name of the new dietary ingredient.
A description of the dietary supplement or
supplements that contain the NDI, including:
Amount of NDI in the dietary supplement.
Conditions of use as per Label
History of use or other evidence of safety.
A signature by a responsible authority from the
company.
www.vediclifesciences.com
Warning
Dietary Supplement with NDI can only reach the
market after 75 days of notification period.
www.vediclifesciences.com
“What to Do” Regulations
Marketing & Post Marketing rules
www.vediclifesciences.com
cGMP Requirements as per August 24, 2007
Regulations of cGMP ensure the quality through out
Manufacturing operations
In process Quality Control procedures
Packaging & labeling
Storage
Cleaning
Designing & Construction of Manufacturing Plants
Testing methods
Handling Customer Complaints
Documentation
As per regulations, manufacturers are required to evaluate
the identity, purity, strength, and composition of their
dietary supplements.
Final cGMP will effective from
June, 2008 for Large companies with employee strength of more
than 500
June, 2009 for companies with less than 500 or more than 20
employees.
June, 2010 for companies with less than 20 employees.
www.vediclifesciences.com
cGMP Requirements as per August 24, 2007
Under the cGMP rule, manufacturers are required to:
Employ qualified employees and supervisors;
Design and construct their physical plant in a manner to protect
dietary ingredients and dietary supplements from becoming
adulterated during manufacturing, packaging, labeling and holding;
Use equipment and utensils that are of appropriate design,
construction, and workmanship for the intended use;
Establish and use master manufacturing and batch production
records;
Establish procedures for quality control operations;
Proper Storage & Distribution in order to maintain efficacy & quality
of product.
Keep a written record of each product complaint related to cGMPs.
Retain records for 1 year past the shelf life date, if shelf life dating is
used, or 2 years beyond the date of distribution of the last batch of
dietary supplements associated with those records
www.vediclifesciences.com
Claims That Can Be Made for Dietary
Supplements
Claims that can be used on food and
dietary supplement labels fall into three
categories:
1) Health claims
2) Qualified Health claims
3) Structure/Function claims
www.vediclifesciences.com
Health Claims
A "health claim" by definition has two essential components:
a substance (whether a food, food component, or dietary ingredient)
a disease or health-related condition.
A statement lacking either one of these components does not meet the
regulatory definition of a health claim.
Nutrition Labeling and Education Act (NLEA), 1990 regulates the
Health claim petitions.
Examples of Health Claims:
“Development of cancer depends on many factors. Eating a diet low in fat
and high in grain products, fruits and vegetables that contain dietary fiber
may reduce your risk of some cancers.”
"diets high in calcium may reduce the risk of osteoporosis"
www.vediclifesciences.com
Qualified Health Claims
Consumer Health Information for Better Nutrition Initiative 2003
provides for the use of qualified health claims to substantiate evidence
for a relationship between a dietary supplement and reduced risk of a
disease or health-related condition.
Label claim should be clear & concise to point limitation of the
Evidence supporting Health Claim.
Both conventional foods and dietary supplements may use qualified
health claims
www.vediclifesciences.com
Structure/Function Claims
Structure/function claims describe
Role of a nutrient or dietary ingredient intended to affect normal
structure or function in humans. Such as, "calcium builds strong bones."
The means by which a nutrient or dietary ingredient acts to maintain
such structure or function, Such as, "fiber maintains bowel regularity,“
General well-being from consumption of a nutrient or dietary ingredient
Benefit related to a nutrient deficiency disease (like vitamin C and
scurvy), with the prevalence of disease in US.
As Structure/Function claims are not pre-approved by FDA,
manufacturers are solely responsible for
Claims are truthful, accurate & not misleading.
Notification to FDA within first 30 days for the usage of claims for the
marketing of product.
A mandatory disclaimer statement as per law.
www.vediclifesciences.com
Claims Substantiation
“Truth in Advertising” is regulated more by FTC (not FDA)
Several Penalties have been levied already
Company is responsible for expressed and implied claims
(thru images, video, etc.)
Randomized Controlled Trials (RCT) are gold standard for
substantiation
Animal studies, Epidemiological studies, meta analyses
may be considered.
www.vediclifesciences.com
Tips for Good Clinical Trials
Follow Good Clinical Practices (ICH GCP)
Qualified, Trained and Professional Team
Scientifically Strong Protocol with a valid Statistical Plan
Maintain Audit trail
Third Party Monitoring by trained Professionals
Internal + External Audit, Quality Assurance
Central Lab for multi-centric trials
AE and SAE reporting
Compliant Data Management
High Quality Unbiased Medical Report and Manuscript Writing
Publication
Follow all available drug guidelines
Outsource / offshore the study to a CRO if required
www.vediclifesciences.com
www.vediclifesciences.com
Label Information
Required label information must appear on:
Principal Display Panel (PDP): It must contain
Statement of identity (name of DS)- Name of DS should Placed
on label parallel to base of package and Should stand out Bold
type and At least 1/2 the size of the largest print on label.
Net quantity of contents statement
Information Panel: It must contain
Name and address of manufacturer, packer, or distributor
Ingredient list
“Nutrition Facts” panel
Information Pane should be placed to the immediate
right of PDP and if not, then next panel to right.
www.vediclifesciences.com
www.vediclifesciences.com
Vedic Corporate Profile
Vedic has so far supported over 36 clinical studies (Phase II/ III) and
more than 400 preclinical across multiple therapeutic areas.
Core offerings entail Preclinical Studies, Consultancy, Project
Management (Phase I to IV), Clinical Data Management, BioStatistics, Medical Writing, Regulatory Consulting and
Pharmacovigilance Services
Founded in 2001, Vedic is a contract research organization that provides
broad-based yet highly tailored drug development & support
services to global Pharma, biotech and Lifesciences players.
www.vediclifesciences.com
Vedic Services
Me
Clinic
al
Dat
a
Clinic
Con
al
s
Tri
ul
als
ta
Mana
n
(Phas
Servic
ge
c
e Ies
me
y
IV) Data
Preclinical
GAP analysis Study
nt
Consultancy
Validation
Feasibility
Analysis
Feasibility
Feasibility
Investigator / Database
Evaluation
Design
Site Selection
Market
Regulatory
Survey
Submission & Data Entry &
Study
analysis &
Tracking
Approval
Protocol
CMC
(IRB/EC &
DCGI)
Data Coding
Study Set – Analytical
Site Initiation
up & Audits
Development
& Validation Assessment Database
Visits
Access
Experimental
Management
Site
& Project
Formulation
Management
Management
Development
& Monitoring Data
Management
Investigational
Reporting
Product
Management
Risk & Query
Closeouts
management
Query
Resolution
Pre
Cli
nic
al
Ot
d
i
c
a
l
Bio
h
e
r
Regul
ato
ry
Ser
Cons
v
Wri
ult
i
t
an
c
Clinical Trial Study Design/i Strategic cy SAE
e
n regulatory
Design
Outline
collection, s
g planning for
evaluation,
specific
classification
countries
& reporting
Sample Size Protocol & its
Calculation
Amendments
Statist
ics
Statistical
Analysis
Plans
Informed
Consent
Document
Pre – IND
meetings
Medical case
reviews
INDs
Adverse event
narration &
coding
Planning &
Patient Diary
Execution of
and Subject NDA and
interim
Emergency
ADNA
analysis
Card
Final
Statistical
Analysis
Clinical /
Statistical
study Report
Statistical
Report
Publication
Support
www.vediclifesciences.com
Applications
for marketing
license
Complete
Pharmacovigil
ance
BA/BE studies
Biochemical
Assays
Thank You
Kindly visit us
at
www.vediclifesciences.com
Contact Us
at
[email protected]
Phone: +91-(0)22-42172300/10
www.vediclifesciences.com